 |
Thalidomide |
|---|---|
| Trade Name | |
| Orphan Indication | The clinical manifestations of mycobacterial infection caused by Mycobacterium tuberculosis and non-tuberculous mycobacteria |
| USA Market Approval | USA |
| USA Designation Date | 1993-01-12 00:00:00 |
| Sponsor | Celgene Corporation;7 Powder Horn Dr.;Warren |
